Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 0.98% 51.50 51.00 52.00 51.50 50.50 51.00 343,631 16:03:16
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1.0 -17.4 -6.7 - 134

Angle Share Discussion Threads

Showing 22776 to 22791 of 24975 messages
Chat Pages: Latest  915  914  913  912  911  910  909  908  907  906  905  904  Older
Glad I managed to buy another 22000 shares over 3 transactions yesterday at just 65p average.
Jam tomorrow company with those imbeciles on the board.

i hope for more hospitals taking up parsotix on the result,

i can easily put down on paper discussion with 100 companies yadda yadda yadda...and milking the company's pot.

As i said..they all need to be kicked out and get an experience CEO with marketing experience.

The key right now is to start announcing deals with a few of those 20 plus organisations. That should take around six months from FDA clearance. As soon as the market sees cashflow this is off to the races. Not long to wait. Bargain.
Positive update from AGL and still more excellent clinical study results - this time next year, things will be really looking up
By and large, the immediate market reaction to AGL's good news RNS is in line with its reaction to good news in general. Perhaps investors needing cash see an opportunity to sell into strength. Perhaps anything that draws attention to a stock just leads to more panic selling. The market may not be behaving rationally but it can do that for a long time.

The RNS is very pleasing, however, and sooner or later ... if we can all live that long ... it will be reflected in the SP, I believe.

I've just added .... play the game
I wonder if the MM's have decent size buy orders and are happy to soak up stock at these lowly prices to fulfill them. I expect to see some meaty trades.
Great RNS that, not even up 1%. Hopefully will go red 😂
What price did you just buy at AmarePoo? What a prawn!

The Convict Post 14135.
"Bit disappointed to be down so much".

He even said he expect this infested mongrel to be a £1 plus, before THIS year ends.

Are you colour blind? Would explain a lot. I can go a lot longer than 60 seconds, just ask you mum if you need to verify that
amaretto, there is a lot of financial pain out there and II's are no different to PI's, they have to have available cash. It is not just II's selling down, PI's are also active.
That rise lasted all of 60 seconds. You would know all about that Zeus19 :) LOLZ
Don't anyone think this reaction is normal mkt behaviour...It's not ! Not on those results
Outstanding Ovarian results (as expected), but reassuring to see the extremley high efficiency…

It would appear IMO that the Algorithm tuning was behind the delayed results, well worth the wait, and well done to AN & the AGL Team and not forgetting all the patients that took place in the study…

I have been invested in AGL for over 14 years, I recall the share count sub +/- 25m at the time, Parsortix was at the time designed to capture Embryos. This long road has lead us to where we are today, on the cusp of a game changing device in Parsortix, which aims to turn the Cancer diagnostic market on its head. I still have an early Parsortix cassette given to me by AN many moons ago, such a simply device, and one which can alter peoples lives both current Cancer patients and future screening for early diagnosis. Having first hand been diagnosed with cancer in 2016 (fortunately all clear now) this doesn’t distract from the check ups I still have to go through annually….. Parsortix would complement my current check up and pick up any recurrence, I would gladly pay for this privately for the piece of mind.

Angles current share price weakness has been driven down to current levels not purely by chance!!!

There is a multi billion $$$ market at stake, and now Parsortix has the Gold Standard FDA clearance the vultures will be circling overhead. Angle is a siting duck at current mcap levels!!!

Why did the current fundraising bypass current Institutional Shareholders?? Many invested at higher prices than the recent 80p raise?? Have some, or all of these been approached with a buyout ?

Hence Ballie Gifford being brought onboard? With an investment case more in line with AN’s longer term view?

Lets assume I wished to buy Angle and I had very deep pockets i.e. Major Pharma…

Short the stock, pick up as much stock in the general market as possible, approach institutional holders to gain further stock at X price, then make a move

The dollar v pound situation, the interview with Abbott stating they are actively looking for acquisitions within the liquid biopsy sector, our tie in with Abbot. The war chests the Major Pharma’s have amassed post covid, will ultimately IMO sweep up Angle for a discounted price which to many new investors would get their vote, long term investors maybe not so, but that’s ultimately out of their hands… the mainly American large Pharma’s with Angle on their shopping spree acquisition list have their fiscal year end in December…. Will they make their move very soon ??

With this in mind I increased my holding by 30% sub placing price, as this will offset my long term view and mcap size target, which I would be happy to see develop, but as above I don’t see this happening as the stakes are far too high for Angle to go this alone.

Looking forward to today presentation and what AN has to say!!!!

Mr K.

Convinced that this will turn and will end up 10-15% up on the day. Big sellers over the last few months had dumped what they wanted, todays buyers are in it for the big money.
Why are sellers continuing to sell at 66p given the positive RNS? Do they not believe AGL will commercialise before needing more cash?
Sellers moving in
Chat Pages: Latest  915  914  913  912  911  910  909  908  907  906  905  904  Older
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20221206 01:02:26